About Hemobras
Hemobras: Revolutionizing the Pharmaceutical Industry in Brazil
Hemobras is a pharmaceutical industry that has been making waves in Brazil since its inception. As a subsidiary of the Ministry of Health, Hemobras has become an essential player in the country's healthcare system, providing high-quality medicines and treatments to thousands of people across the nation.
The company's mission is to reduce Brazil's dependence on foreign pharmaceuticals by producing locally-made products that meet international standards. Hemobras' commitment to quality and innovation has made it one of the most respected names in the industry, not just within Brazil but also globally.
Hemobras was founded in 2004 with a vision to transform Brazil into a self-sufficient nation when it comes to pharmaceuticals. The company started with just one plant located in Recife, Pernambuco, but over time it expanded its operations across different regions of Brazil.
Today, Hemobras operates four plants spread across Recife (Pernambuco), Goiana (Pernambuco), Maringá (Paraná) and Brasília (Federal District). These plants are equipped with state-of-the-art technology and employ highly skilled professionals who work tirelessly to ensure that every product meets stringent quality standards.
One of Hemobras' most significant achievements is its production of Factor VIII concentrate for hemophilia treatment. This product was previously imported from other countries at great expense but now produced locally by Hemobrás at much lower costs. This achievement alone has saved millions for Brazilian patients suffering from hemophilia while also reducing their dependence on foreign imports.
Apart from Factor VIII concentrate for hemophilia treatment, Hemobrás produces several other essential medicines such as immunoglobulin G (IgG), albumin solution, fibrinogen concentrate among others. These products are used extensively across various medical fields such as oncology, neurology and infectious diseases.
Hemobras' commitment to quality is evident in its rigorous testing and certification processes. The company has obtained several certifications such as the Good Manufacturing Practices (GMP) certification, ISO 9001:2015, and ISO 14001:2015. These certifications are a testament to Hemobras' dedication to producing high-quality products that meet international standards.
Hemobras also invests heavily in research and development (R&D) activities. The company has a dedicated R&D team that works on developing new products and improving existing ones. Hemobras collaborates with several universities, research institutions, and other pharmaceutical companies to advance its R&D efforts.
In addition to its core business of producing pharmaceuticals, Hemobras also engages in social responsibility initiatives aimed at improving the lives of people across Brazil. The company supports various programs such as blood donation campaigns, educational initiatives for children from low-income families among others.
In conclusion, Hemobras is an essential player in Brazil's healthcare system that has revolutionized the country's pharmaceutical industry by reducing dependence on foreign imports while providing high-quality medicines at affordable prices. With its commitment to quality, innovation and social responsibility initiatives, Hemobras is poised for continued success both within Brazil and globally.